Role of hypoxia-inducible factor-1α, carbonic anhydrase-IX, glucose transporter-1 and vascular endothelial growth factor associated with lymph node metastasis and recurrence in patients with locally advanced cervical cancer

Iwasaki,Keita; Yabushita,Hiromitsu; Ueno,Taiki; Wakatsuki,Akihiko

doi:10.3892/ol.2015.3524

Role of hypoxia-inducible factor-1α, carbonic anhydrase-IX, glucose transporter-1 and vascular endothelial growth factor associated with lymph node metastasis and recurrence in patients with locally advanced cervical cancer

Authors:
- Keita Iwasaki
- Hiromitsu Yabushita
- Taiki Ueno
- Akihiko Wakatsuki
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, School of Medicine, Aichi Medical University, Nagakute, Aichi 480‑1195, Japan
Published online on: July 23, 2015 https://doi.org/10.3892/ol.2015.3524
Pages: 1970-1978
Copyright: © Iwasaki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to determine whether the expression of hypoxia-inducible factor-1α (HIF-1α), carbonic anhydrase-IX (CA-IX), glucose transporter-1 (GLUT-1) or vascular endothelial growth factor (VEGF) was associated with the clinicopathological characteristics, lymph node metastasis or progression‑free survival of patients with cervical cancer. Tumor tissue samples were obtained from 54 cervical cancer patients who had undergone radical hysterectomy. The expression of HIF‑1α, CA‑IX, GLUT‑1 and VEGF was analyzed by immunohistochemical staining. Of the 54 cases, 28 were positive for HIF‑1α, 35 for CA‑IX, 40 for GLUT‑1 and 23 for VEGF. It was revealed that HIF‑1α expression was correlated with tumor stage and histology, CA‑IX expression with tumor stage, tumor size, lymph node metastasis and lymph‑vascular space involvement, GLUT‑1 expression with tumor stage and lymph‑vascular space involvement, and VEGF expression with microvessel density. The multivariate regression analysis indicated that CA‑IX expression and lymph‑vascular space involvement were independent variables associated with lymph node metastasis. Progression‑free survival was shorter for patients who were positive for CA‑IX or VEGF expression than for those who were negative for CA‑IX or VEGF expression. The progression‑free survival of patients treated with radiotherapy or chemo‑radiotherapy following radical hysterectomy was also shorter for patients with positive CA‑IX expression. These findings suggest that CA‑IX expression is a possible risk factor for lymph node metastasis and disease recurrence in locally advanced cervical cancer patients.

View Figures

View References

1	Tewari KS and Monk BJ: Invasive cervical cancerClinical Gynecologic Oncology. DiSaia PJ and Creaseman WT: 8th. Mosby; Philadelphia, PA: pp. 51–120. 2012, View Article : Google Scholar
2	Pecorelli S: Revised FIGO staging for the vulva, cervix and endometrium. Int J Gynaecol Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
3	Creasman WT and Kohler MF: Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol. 92:525–529. 2004. View Article : Google Scholar : PubMed/NCBI
4	Narayan K, Fisher R and Bernshaw D: Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy. Int J Gynecol Cancer. 16:623–630. 2006. View Article : Google Scholar : PubMed/NCBI
5	Biewenga P, van der Velden J, Mol BW, et al: Validation of existing prognostic models in patients with early-stage cervical cancer. Gynecol Oncol. 115:277–284. 2009. View Article : Google Scholar : PubMed/NCBI
6	Kurokawa T, Miyamoto M, Kato K, et al: Overexpression of hypoxia-inducible-factor 1alpha (HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer. 89:1042–1047. 2003. View Article : Google Scholar : PubMed/NCBI
7	Schindl M, Schoppmann SF, Samonigg H, et al: Austrian Breast and Colorectal Cancer Study Group: Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 8:1831–1837. 2002.PubMed/NCBI
8	Unruh A, Ressel A, Mohamed HG, et al: The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene. 22:3213–3220. 2003. View Article : Google Scholar : PubMed/NCBI
9	Greijer AE, de Jong MC, Scheffer GL, Shvarts A, van Diest PJ and van der Wall E: Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells. Cell Oncol. 27:43–49. 2005.PubMed/NCBI
10	Greijer AE, van der Groep P, Kemming D, et al: Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol. 206:291–304. 2005. View Article : Google Scholar : PubMed/NCBI
11	Huang LE, Arany Z, Livingston DM and Bunn HF: Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem. 271:32253–32259. 1996. View Article : Google Scholar : PubMed/NCBI
12	Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 15:551–578. 1999. View Article : Google Scholar : PubMed/NCBI
13	Semenza GL: HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985). 88:1474–1480. 2000.PubMed/NCBI
14	Ratcliffe PJ, O'Rourke JF, Maxwell PH and Pugh CW: Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol. 201:1153–1162. 1998.PubMed/NCBI
15	VaughanJones RD and Spitzer KW: Role of bicarbonate in the regulation of intracellular pH in the mammalian ventricular myocyte. Biochem Cell Biol. 80:579–596. 2002. View Article : Google Scholar : PubMed/NCBI
16	Behrooz A and Ismail-Beigi F: Stimulation of glucose transport by hypoxia: Signals and mechanisms. News Physiol Sci. 14:105–110. 1999.PubMed/NCBI
17	Pedersen MW, Holm S, Lund EL, Højgaard L and Kristjansen PE: Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia. 3:80–87. 2001. View Article : Google Scholar : PubMed/NCBI
18	Robertson N, Potter C and Harris AL: Role of carbonic anhydrase IX in human tumor cell growth, survival and invasion. Cancer Res. 64:6160–6165. 2004. View Article : Google Scholar : PubMed/NCBI
19	Giatromanolaki A, Koukourakis MI, Sivridis E, et al: Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res. 61:7992–7998. 2001.PubMed/NCBI
20	Loncaster JA, Harris AL, Davidson SE, et al: Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61:6394–6399. 2001.PubMed/NCBI
21	Younes M, Lechago LV, Somoano JR, Mosharaf M and Lechago J: Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res. 56:1164–1167. 1996.PubMed/NCBI
22	Clavo AC, Brown RS and Wahl RL: Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 36:1625–1632. 1995.PubMed/NCBI
23	Obermair A, BancherTodesca D, Bilgi S, et al: Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst. 89:1212–1217. 1997. View Article : Google Scholar : PubMed/NCBI
24	Monk BJ, Tewari KS and Koh WJ: Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 25:2952–2965. 2007. View Article : Google Scholar : PubMed/NCBI
25	Uemura H, Fujimoto K, Tanaka M, et al: A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma. Clin Cancer Res. 12:1768–1775. 2006. View Article : Google Scholar : PubMed/NCBI
26	Tewari KS, Sill MW, Long HJ III, et al: Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 370:734–743. 2014. View Article : Google Scholar : PubMed/NCBI
27	Peters WA III, Liu PY, Barrett RJ II, et al: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 18:1606–1613. 2000.PubMed/NCBI
28	Liao SY, Darcy KM, Randall LM, et al: Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 116:452–458. 2010. View Article : Google Scholar : PubMed/NCBI
29	Airley R, Loncaster J, Davidson S, et al: Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res. 7:928–934. 2001.PubMed/NCBI
30	Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD and West CM: Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer. 83:620–625. 2000. View Article : Google Scholar : PubMed/NCBI
31	Cheng WF, Chen CA, Lee CN, Wei LH, Hsieh FJ and Hsieh CY: Vascular endothelial growth factor and prognosis of cervical carcinoma. Obstet Gynecol. 96:721–726. 2000. View Article : Google Scholar : PubMed/NCBI
32	Alitalo A and Detmar M: Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene. 31:4499–4508. 2012. View Article : Google Scholar : PubMed/NCBI
33	Hashimoto I, Kodama J, Seki N, Hongo A, Yoshinouchi M, Okuda H and Kudo T: Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer. 85:93–97. 2001. View Article : Google Scholar : PubMed/NCBI